Hubertus von Baumbach

Hubertus von Baumbach (born 1967) is a German businessman who is the chairman and CEO of Boehringer Ingelheim, Germany's second largest pharmaceutical company.[2]

Hubertus von Baumbach
Born1966 or 1967 (age 55–56)[1]
NationalityGerman
EducationMassachusetts Institute of Technology
OccupationBusinessman
TitleChairman and CEO, Boehringer Ingelheim

Early life and education

The son of Erich von Baumbach and Ulrike Boehringer, Hubertus von Baumbach is also a great-grandson of the company's founder Albert Boehringer.[1] He has a law degree and an MBA from the Massachusetts Institute of Technology.[3][2]

Career

Baumbach joined Boehringer Ingelheim in 2001.[3]

In November 2015, it was announced that Baumbach, who had been CFO, was appointed as chief executive, succeeding Andreas Barner in June 2016.[1][2] At the time, this made him the first member of the family at the helm in 25 years.[4] Within his first six months, he launched the biggest acquisition in the company's history (an asset swap deal with French rival Sanofi), followed by a reorganization to give the group a more decentralized divisional structure.[5]

In his capacity at Boehringer Ingelheim, Baumbach was part of Chancellor Angela Merkel’s delegation on three state visits to China.[6]

Other activities

Corporate boards

Non-profit organizations
  • Federation of German Industries (BDI), Member of the Presidium (2018-2019)[9]
  • German Chemical Industry Association (VCI), Member of the Executive Committee[10]
  • Baden-Badener Unternehmer-Gespräche (BBUG), Member of the Board of Trustees[11]
  • Cultural Foundation of the Federal States, Member of the Board of Trustees[12]
  • Städel Museum, Member of the Administration[13] and the Board of Trustees[14]
  • Stiftung Tausendgut, Member of the Board of Trustees[15]

References
  1. Editorial, Reuters (6 November 2015). "Boehringer appoints first CEO from founding family in 25 years". reuters.com. Retrieved 7 November 2018. {{cite news}}: |first= has generic name (help)
  2. "Drug firm Boehringer Ingelheim on a high". handelsblatt.com. 27 April 2018. Retrieved 7 November 2018.
  3. "Board of Managing Directors - boehringer-ingelheim.com". boehringer-ingelheim.com. Retrieved 7 November 2018.
  4. Patricia Weiss and Maria Sheahan (November 6, 2015), Boehringer appoints first CEO from founding family in 25 years Reuters .
  5. Siegfried Hofmann (April 27, 2018), Drug firm Boehringer Ingelheim on a high Handelsblatt .
  6. Christian Schlesiger (September 8, 2017), Siemens-Chef Kaeser am häufigsten bei Delegationsreisen dabei Wirtschaftswoche.
  7. Members of the Advisory Board, 2010 Deutsche Bank.
  8. 2015 Annual Report Landesbank Baden-Württemberg (LBBW).
  9. Presidium Federation of German Industries (BDI).
  10. "Vorstand & Präsidium - Verband der Chemischen Industrie e.V. (VCI)". www.vci.de (in German). Retrieved 2017-06-01.
  11. Board of Trustees Baden-Badener Unternehmer-Gespräche (BBUG).
  12. Board of Trustees Cultural Foundation of the Federal States.
  13. Administration Städel Museum.
  14. Board of Trustees Städel Museum.
  15. Board of Trustees Stiftung Tausendgut.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.